Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Transcatheter arterial chemoembolization Stories

2014-03-26 16:15:10

In a series of studies involving 140 American men and women with liver tumors, researchers at Johns Hopkins have used specialized 3-D MRI scans to precisely measure living and dying tumor tissue to quickly show whether highly toxic chemotherapy – delivered directly through a tumor's blood supply – is working. The investigators say their findings, to be presented March 22-27 in San Diego at the annual meeting of the Society of Interventional Radiology, are the first "proof of principle"...

2014-03-24 16:23:03

JVIR Editor's Award for Outstanding Clinical Research Paper on Lens Opacities in Catheterization Personnel Presented to International Authority on Radiation Protection; Outstanding Laboratory Investigation Article Examines Therapies That Help Chemotherapy Patients SAN DIEGO, March 24, 2014 /PRNewswire-USNewswire/ -- The Journal of Vascular and Interventional Radiology--the Society of Interventional Radiology's peer-reviewed scientific journal--together with SIR Foundation, will...

2014-02-03 04:20:02

Tokyo, Feb 3, 2014 - (JCN Newswire) - Eisai Co., Ltd. announced today that it will launch the vascular embolization device DC Bead(R) (specially controlled medical device) in Japan on February 4.DC Bead contains hydrophilic microspheres made from cross-linked polyvinyl alcohol polymer. Developed by Biocompatibles UK Limited (Biocompatibles), a BTG International group company, as an intravascular embolization device, it is injected via catheter into targeted blood...

2013-12-13 16:24:24

PALO ALTO, Calif., Dec. 13, 2013 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, is pleased to announce that it has treated the final patient of its Phase I clinical trial which evaluates the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma (HCC), the most common type of liver cancer. The...

2013-09-25 08:29:28

Adoption of Drug-Eluting Beads, Microspheres and Radioembolization Spheres Will Drive Overall Market Growth, According to Millennium Research Group TORONTO, Sept. 25, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the Japanese transcatheter embolization and occlusion (TEO) device market will expand as a number of new products enter the market through 2021. The embolization particle segment will...

2013-07-10 04:20:41

LONDON, July 10, 2013 /PRNewswire/ -- A decade ago, there was little interest in interventional cancer therapies. Five years ago, newly diagnosed cases of different types of cancer stood at about 12.7 million with 7.6 million related deaths registered. According to the WHO GLOBOCAN database, the top three diagnosed cancer forms in 2008 included lung - 1.61 million, breast - 1.38 million, and colorectal - 1.23 million, while the most common types of cancer with leading death rate were...

2013-06-20 12:31:16

BOLOGNA, Italy, June 20, 2013 /PRNewswire/ -- Based on New Data from Multi-Centre ENRY Evaluation of 325 Patients, Authors Suggest that Radioembolisation May Be a Well-Tolerated and Effective Option for an Increasing Population of Older Patients Results of a new analysis by members of the multi-centre European Network on Radioembolisation with Yttrium-90 Resin Microspheres (ENRY), published on-line in the Journal of Hepatology, the...

2013-04-26 11:58:17

New scoring system defines patients who achieve most benefit from TACE Data from a number of clinical trials presented today at the International Liver Congress 2013 shed new light on the use of TACE and SIRT in the treatment of hepatocellular carcinoma (HCC). Transarterial chemoembolization (TACE) is a technique in which small particles designed to block blood vessels mixed or coated with chemotherapeutic drugs are injected directly into an artery supplying the tumor; it has become a...

2013-04-13 23:03:40

Surefire Medical's first-in-class antireflux infusion system can accommodate smaller vessels and selective procedures in direct-to-tumor cancer treatment, and significantly increases penetration of embolics to 99.9 percent compared to 72.8 percent when using end-hole catheters. New Orleans, LA (PRWEB) April 13, 2013 Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced the launch...

2012-05-01 21:14:22

Abdominal tumors involving both roots of the celiac and superior mesenteric artery (SMA) are deemed unresectable by conventional surgical methods, as removal would cause necrosis of the organs that are supplied by those blood vessels. A case report published in the journal American Journal of Transplantation presents a novel surgical technique that enables surgeons to remove tumors that are unresectable by the usual surgical techniques. Led by Tomoaki Kato, MD, FACS, of Columbia...